Parkinson's drugs

Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company that focuses on the development and commercialization of medicines for the treatment of neurological and central nervous system disorders, surged higher by more than 20 percent on Monday. According to Fierce...